Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
13F holders, Q2 2025
Institutional positions in Aspire Biopharma Holdings, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q1 2025
- Shares held
- 2.04M
- +608.3K (+42.4%) vs. Q1 2025
- Total value
- $544.7K
- −$331.0K (−37.8%) vs. Q1 2025
- New holders
- 10
- 4 more added
- Sold out
- 9
- 0 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $250.9K |
| Q1 2026 | 15 | $371.9K |
| Q4 2025 | 30 | $899.8K |
| Q3 2025 | 25 | $645.6K |
| Q2 2025 | 16 | $544.7K |
| Q1 2025 | 15 | $875.8K |
| Q4 2024 | 3 | $5.36M |
| Q3 2024 | 2 | $149.6K |
| Q2 2024 | 3 | $90.4K |
| Q1 2024 | 19 | $18.1M |
| Q4 2023 | 21 | $17.9M |
| Q3 2023 | 21 | $18.2M |
| Q2 2023 | 14 | $17.0M |
| Q1 2023 | 59 | $267.9M |
| Q4 2022 | 57 | $264.7M |
| Q3 2022 | 61 | $260.8M |
| Q2 2022 | 54 | $243.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Procyon Private Wealth Partners, LLC | 648,411 | $174.4K | 0.02% | +549,911+558.3% | Added |
| Crewe Advisors LLC | 626,854 | $168.6K | 0.02% | +313,427+100.0% | Added |
| Optivise Advisory Services LLC | 235,106 | $63.2K | 0.03% | +128,660+120.9% | Added |
| Jane Street Group, LLC | 152,552 | $41.0K | 0.00% | +131,533+625.8% | Added |
| VR Advisory Services Ltd | 97,391 | $26.2K | 0.01% | +97,391 | New |
| Three Seasons Wealth, LLC | 75,000 | $20.2K | 0.00% | +75,000 | New |
| Periscope Capital Inc. | 75,000 | $15.0K | 0.01% | 00.0% | Unchanged |
| Hallmark Capital Management Inc | 40,000 | $10.8K | 0.00% | +40,000 | New |
| Platform Technology Partners | 37,611 | $10.1K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,701 | $5.03K | 0.00% | +18,701 | New |
| Scientech Research LLC | 16,514 | $4.44K | 0.00% | +16,514 | New |
| Allred Capital Management, LLC | 11,185 | $3.01K | 0.00% | +11,185 | New |
| CIBC Private Wealth Group, LLC | 7,108 | $1.91K | 0.00% | +7,108 | New |
| Raymond James Financial Inc | 2,500 | $673 | 0.00% | +2,500 | New |
| Bank of America Corp | 271 | $73 | 0.00% | +271 | New |
| Advisor Group Holdings, Inc. | 100 | $26 | 0.00% | +100 | New |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −516,845−100.0% | Sold out |
| Harraden Circle Investments, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −29,945−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −27,413−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,901−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,694−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,023−100.0% | Sold out |
| Reyes Financial Architecture, Inc. | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |